financetom
Business
financetom
/
Business
/
Deutsche Bank Gives Its Outlook of Bank of England Policy Action
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Deutsche Bank Gives Its Outlook of Bank of England Policy Action
Oct 22, 2024 12:10 PM

07:38 AM EDT, 10/22/2024 (MT Newswires) -- Deutsche Bank said it now shifted its call to a two-stage rate-cutting cycle at the Bank of England.

In Stage 1, the bank expects the BoE's Monetary Policy Committee to move the Bank Rate sequentially over the next few months, taking the Bank Rate down to 3.75% by May 2025.

Following that, in Stage 2, Deutsche Bank estimates the MPC to move to a quarterly pace of rate cuts all the way down to 3% -- the mid-point of the bank's medium-term neutral rate estimates.

The risk of 50bps rate cuts has risen in recent weeks, but the conditions for 'forceful' rate cuts have yet to be met, and the window for any outsized rate cuts is likely to be small, stated Deutsche Bank.

Importantly, the bank still sees risks skewed to a higher terminal rate -- especially in light of growing expectations of looser fiscal policy in the British Fall Budget -- with the MPC potentially pausing following Stage 1 of the easing cycle, or at 3.75%.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bezos' Blue Origin delays New Glenn debut launch
Bezos' Blue Origin delays New Glenn debut launch
Jan 13, 2025
WASHINGTON, Jan 13 (Reuters) - Jeff Bezos' Blue Origin called off the launch of its New Glenn rocket after a few anomalies during the mission countdown on Monday, postponing by at least a day an inaugural attempt to reach orbit and compete with SpaceX in the satellite launch market. ...
GSK to Acquire Oncology Firm IDRx for Up to $1.15 Billion
GSK to Acquire Oncology Firm IDRx for Up to $1.15 Billion
Jan 13, 2025
03:21 AM EST, 01/13/2025 (MT Newswires) -- GSK (GSK) has agreed to acquire oncology company IDRx for up to $1.15 billion, the companies said Monday. The consideration includes $1 billion in an upfront payment, and up to $150 million in potential regulatory-based milestone payments. GSK will also be responsible for milestone and royalty payments owed to Merck KGaA related to...
Arcellx Insider Sold Shares Worth $1,355,024, According to a Recent SEC Filing
Arcellx Insider Sold Shares Worth $1,355,024, According to a Recent SEC Filing
Jan 13, 2025
03:22 AM EST, 01/13/2025 (MT Newswires) -- Michelle Gilson, Chief Financial Officer, on January 07, 2025, sold 18,009 shares in Arcellx ( ACLX ) for $1,355,024. Following the Form 4 filing with the SEC, Gilson has control over a total of 9,582 shares of the company, with 9,582 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1786205/000141588925001345/xslF345X05/form4-01112025_020131.xml ...
Arcellx Insider Sold Shares Worth $2,263,942, According to a Recent SEC Filing
Arcellx Insider Sold Shares Worth $2,263,942, According to a Recent SEC Filing
Jan 13, 2025
03:22 AM EST, 01/13/2025 (MT Newswires) -- Rami Elghandour, Director, President, Chief Executive Officer and Chairman of the Board, on January 07, 2025, sold 30,311 shares in Arcellx ( ACLX ) for $2,263,942. Following the Form 4 filing with the SEC, Elghandour has control over a total of 117,275 shares of the company, with 117,275 shares held directly. SEC Filing:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved